SARS-CoV-2-specific antibody and T cell response kinetics according to symptom severity

14Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Data on the longevity of humoral and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with coronavirus disease 2019 (COVID-19) are limited. We evaluated the detailed kinetics of antibody and T-cell responses at the acute, convalescent, and post-convalescent phases in COVID-19 patients with a wide range of severity. We enrolled patients with COVID-19 prospectively from four hospitals and one community treatment center between February 2020 and January 2021. symptom severity was classified as mild, moderate, or severe/critical. Patient blood samples were collected at 1 week (acute), 1 month (convalescent), and 2 months after symptom onset (post-convalescent). Human SARS-CoV-2 IgG and IgM antibodies were measured using in-house-developed ELISA. The SARS-CoV-2-specific T-cell responses against overlapping peptides of spike proteins and nucleoprotein were measured by interferon-g enzyme-linked immunospot assays. Twenty-five COVID-19 patients were analyzed (mild, n 5 5; moderate, n 5 9; severe/critical, n 5 11). IgM and IgG antibody responses peaked at 1 month after symptom onset and decreased at 2 months. IgG response levels were significantly greater in the severe/critical group compared with other groups. Interferon-g-producing T-cell responses increased between 1 week and 1 month after symptom onset, and had a trend toward decreasing at 2 months, but did not show significant differences according to severity. Our data indicate that SARS-CoV-2-specific antibody responses were greater in those with severe symptoms and waned after reaching a peak around 1 month after symptom onset. However, SARS-CoV-2-specific T-cell responses were not significantly different according to symptom severity, and decreased slowly during the post-convalescent phase.

Cite

CITATION STYLE

APA

Ji, Y. K., Ji-Soo, K., Seongman, B., Hye, H. C., Joon, S. L., Min-Chul, K., … Sung-Han, K. (2021). SARS-CoV-2-specific antibody and T cell response kinetics according to symptom severity. American Journal of Tropical Medicine and Hygiene, 105(2), 395–400. https://doi.org/10.4269/ajtmh.20-1594

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free